| Primary |
| Attention Deficit/hyperactivity Disorder |
79.2% |
| Autism |
4.2% |
| Tic |
2.8% |
| Bipolar Disorder |
1.4% |
| Depression |
1.4% |
| Educational Problem |
1.4% |
| Impulse-control Disorder |
1.4% |
| Incorrect Dose Administered |
1.4% |
| Nightmare |
1.4% |
| Obsessive-compulsive Disorder |
1.4% |
| Oppositional Defiant Disorder |
1.4% |
| Somnolence |
1.4% |
| Tourette's Disorder |
1.4% |
|
| Convulsion |
9.8% |
| Tic |
9.8% |
| Vomiting |
9.8% |
| Weight Decreased |
7.3% |
| Autism |
4.9% |
| Feeling Jittery |
4.9% |
| Irritability |
4.9% |
| Negative Thoughts |
4.9% |
| Overdose |
4.9% |
| Product Quality Issue |
4.9% |
| Product Substitution Issue |
4.9% |
| Psychotic Disorder |
4.9% |
| Therapeutic Response Unexpected With Drug Substitution |
4.9% |
| Weight Increased |
4.9% |
| Abdominal Pain Upper |
2.4% |
| Abnormal Behaviour |
2.4% |
| Aggression |
2.4% |
| Alopecia |
2.4% |
| Aplastic Anaemia |
2.4% |
| Aura |
2.4% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
63.1% |
| Bipolar Disorder |
8.9% |
| Product Used For Unknown Indication |
7.8% |
| Drug Use For Unknown Indication |
5.6% |
| Asperger's Disorder |
1.7% |
| Diabetes Mellitus |
1.1% |
| Fatigue |
1.1% |
| Growth Retardation |
1.1% |
| Hypertension |
1.1% |
| Ill-defined Disorder |
1.1% |
| Insomnia |
1.1% |
| Neck Pain |
1.1% |
| Oppositional Defiant Disorder |
1.1% |
| Abnormal Behaviour |
0.6% |
| Anxiety |
0.6% |
| Blood Glucose Abnormal |
0.6% |
| Blood Triglycerides |
0.6% |
| Brain Injury |
0.6% |
| Cough |
0.6% |
| Depression |
0.6% |
|
| Weight Decreased |
19.0% |
| Negative Thoughts |
10.3% |
| Skin Discolouration |
8.6% |
| Tachycardia |
6.9% |
| Convulsion |
5.2% |
| Suicidal Ideation |
5.2% |
| Aggression |
3.4% |
| Aplastic Anaemia |
3.4% |
| Asthenia |
3.4% |
| Cognitive Disorder |
3.4% |
| Drug Effect Decreased |
3.4% |
| Irritability |
3.4% |
| Neutrophil Count Decreased |
3.4% |
| Off Label Use |
3.4% |
| Pharmaceutical Product Complaint |
3.4% |
| Shoulder Deformity |
3.4% |
| Tic |
3.4% |
| Vomiting |
3.4% |
| Abnormal Behaviour |
1.7% |
| Agitation |
1.7% |
|
| Concomitant |
| Attention Deficit/hyperactivity Disorder |
32.5% |
| Product Used For Unknown Indication |
18.8% |
| Drug Use For Unknown Indication |
10.8% |
| Depression |
6.0% |
| Bipolar Disorder |
5.6% |
| Multiple Sclerosis |
2.6% |
| Fatigue |
2.2% |
| Insomnia |
2.2% |
| Oppositional Defiant Disorder |
2.2% |
| Acne |
1.9% |
| Obsessive-compulsive Disorder |
1.9% |
| Autism |
1.7% |
| Growth Hormone Deficiency |
1.7% |
| Anxiety |
1.6% |
| Muscle Spasms |
1.6% |
| Pain |
1.6% |
| Contraception |
1.4% |
| Hypersensitivity |
1.4% |
| Affective Disorder |
1.3% |
| Asperger's Disorder |
1.1% |
|
| Product Quality Issue |
14.9% |
| No Adverse Event |
11.2% |
| Weight Increased |
8.2% |
| Vomiting |
7.5% |
| Drug Ineffective |
6.7% |
| Wrong Technique In Drug Usage Process |
5.2% |
| Application Site Erythema |
4.5% |
| Drug Administration Error |
4.5% |
| Somnolence |
4.5% |
| Tardive Dyskinesia |
4.5% |
| Suicidal Ideation |
3.7% |
| Agitation |
3.0% |
| Ileal Stenosis |
3.0% |
| Nausea |
3.0% |
| Off Label Use |
3.0% |
| Pneumonia |
3.0% |
| Tic |
3.0% |
| Convulsion |
2.2% |
| Hallucination, Visual |
2.2% |
| Injection Site Urticaria |
2.2% |
|
